Johnson & Johnson Innovation today announced the opening of JLABS @ Toronto, a 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices, and access to scientific and capital funding experts as they work to build early-stage companies.
The new JLABS facility can accommodate up to 50 startups and opens with 22 companies that represent a range of sectors. This first group of resident startups includes the seven winners of the JLABS @ Toronto Quick Fire Challenge.
“The expansion of JLABS into Canada helps further Johnson & Johnson Innovation’s mission to discover and advance the best science in the world that has the most potential to help patients and consumers,” said Paul Stoffels, M.D., Chief Scientific Officer and Worldwide Chairman, Pharmaceuticals, Johnson & Johnson. “We are confident that JLABS @ Toronto will support a vibrant ecosystem of startups and entrepreneurs with access to the world-class expertise and technology within our global network.”
JLABS @ Toronto builds on the JLABS model and is the sixth JLABS facility to open and the first outside of the United States.
“Ontario is one of North America’s leading centres for life sciences research,” said Ontario Premier Kathleen Wynne. “Our government’s partnership in the first JLABS in Canada will support an exciting new wave of startups, create good jobs and strengthen Ontario’s position as a hub of the knowledge- economy.”
JLABS @ Toronto is located at the MaRS Discovery District.